Cargando…

Myristoylated Alanine‐Rich Protein Kinase Substrate (MARCKS) Regulates Small GTPase Rac1 and Cdc42 Activity and Is a Critical Mediator of Vascular Smooth Muscle Cell Migration in Intimal Hyperplasia Formation

BACKGROUND: Transcription of the myristoylated alanine‐rich C kinase substrate (MARCKS) is upregulated in animal models of intimal hyperplasia. MARCKS knockdown inhibits vascular smooth muscle cell (VSMC) migration in vitro; however, the mechanism is as yet unknown. We sought to elucidate the mechan...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Dan, Makkar, George, Strickland, Dudley K., Blanpied, Thomas A., Stumpo, Deborah J., Blackshear, Perry J., Sarkar, Rajabrata, Monahan, Thomas S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845127/
https://www.ncbi.nlm.nih.gov/pubmed/26450120
http://dx.doi.org/10.1161/JAHA.115.002255
_version_ 1782428885204336640
author Yu, Dan
Makkar, George
Strickland, Dudley K.
Blanpied, Thomas A.
Stumpo, Deborah J.
Blackshear, Perry J.
Sarkar, Rajabrata
Monahan, Thomas S.
author_facet Yu, Dan
Makkar, George
Strickland, Dudley K.
Blanpied, Thomas A.
Stumpo, Deborah J.
Blackshear, Perry J.
Sarkar, Rajabrata
Monahan, Thomas S.
author_sort Yu, Dan
collection PubMed
description BACKGROUND: Transcription of the myristoylated alanine‐rich C kinase substrate (MARCKS) is upregulated in animal models of intimal hyperplasia. MARCKS knockdown inhibits vascular smooth muscle cell (VSMC) migration in vitro; however, the mechanism is as yet unknown. We sought to elucidate the mechanism of MARCKS‐mediated motility and determine whether MARCKS knockdown reduces intimal hyperplasia formation in vivo. METHODS AND RESULTS: MARCKS knockdown blocked platelet‐derived growth factor (PDGF)‐induced translocation of cortactin to the cell cortex, impaired both lamellipodia and filopodia formation, and attenuated motility of human coronary artery smooth muscle cells (CASMCs). Activation of the small GTPases, Rac1 and Cdc42, was prevented by MARCKS knockdown. Phosphorylation of MARCKS resulted in a transient shift of MARCKS from the plasma membrane to the cytosol. MARCKS knockdown significantly decreased membrane‐associated phosphatidylinositol 4,5‐bisphosphate (PIP (2)) levels. Cotransfection with an intact, unphosphorylated MARCKS, which has a high binding affinity for PIP (2), restored membrane‐associated PIP (2) levels and was indispensable for activation of Rac1 and Cdc42 and, ultimately, VSMC migration. Overexpression of MARCKS in differentiated VSMCs increased membrane PIP (2) abundance, Rac1 and Cdc42 activity, and cell motility. MARCKS protein was upregulated early in the development of intimal hyperplasia in the murine carotid ligation model. Decreased MARKCS expression, but not total knockdown, attenuated intimal hyperplasia formation. CONCLUSIONS: MARCKS upregulation increases VSMC motility by activation of Rac1 and Cdc42. These effects are mediated by MARCKS sequestering PIP (2) at the plasma membrane. This study delineates a novel mechanism for MARCKS‐mediated VSMC migration and supports the rational for MARCKS knockdown to prevent intimal hyperplasia.
format Online
Article
Text
id pubmed-4845127
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-48451272016-04-27 Myristoylated Alanine‐Rich Protein Kinase Substrate (MARCKS) Regulates Small GTPase Rac1 and Cdc42 Activity and Is a Critical Mediator of Vascular Smooth Muscle Cell Migration in Intimal Hyperplasia Formation Yu, Dan Makkar, George Strickland, Dudley K. Blanpied, Thomas A. Stumpo, Deborah J. Blackshear, Perry J. Sarkar, Rajabrata Monahan, Thomas S. J Am Heart Assoc Original Research BACKGROUND: Transcription of the myristoylated alanine‐rich C kinase substrate (MARCKS) is upregulated in animal models of intimal hyperplasia. MARCKS knockdown inhibits vascular smooth muscle cell (VSMC) migration in vitro; however, the mechanism is as yet unknown. We sought to elucidate the mechanism of MARCKS‐mediated motility and determine whether MARCKS knockdown reduces intimal hyperplasia formation in vivo. METHODS AND RESULTS: MARCKS knockdown blocked platelet‐derived growth factor (PDGF)‐induced translocation of cortactin to the cell cortex, impaired both lamellipodia and filopodia formation, and attenuated motility of human coronary artery smooth muscle cells (CASMCs). Activation of the small GTPases, Rac1 and Cdc42, was prevented by MARCKS knockdown. Phosphorylation of MARCKS resulted in a transient shift of MARCKS from the plasma membrane to the cytosol. MARCKS knockdown significantly decreased membrane‐associated phosphatidylinositol 4,5‐bisphosphate (PIP (2)) levels. Cotransfection with an intact, unphosphorylated MARCKS, which has a high binding affinity for PIP (2), restored membrane‐associated PIP (2) levels and was indispensable for activation of Rac1 and Cdc42 and, ultimately, VSMC migration. Overexpression of MARCKS in differentiated VSMCs increased membrane PIP (2) abundance, Rac1 and Cdc42 activity, and cell motility. MARCKS protein was upregulated early in the development of intimal hyperplasia in the murine carotid ligation model. Decreased MARKCS expression, but not total knockdown, attenuated intimal hyperplasia formation. CONCLUSIONS: MARCKS upregulation increases VSMC motility by activation of Rac1 and Cdc42. These effects are mediated by MARCKS sequestering PIP (2) at the plasma membrane. This study delineates a novel mechanism for MARCKS‐mediated VSMC migration and supports the rational for MARCKS knockdown to prevent intimal hyperplasia. John Wiley and Sons Inc. 2015-10-08 /pmc/articles/PMC4845127/ /pubmed/26450120 http://dx.doi.org/10.1161/JAHA.115.002255 Text en © 2015 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Research
Yu, Dan
Makkar, George
Strickland, Dudley K.
Blanpied, Thomas A.
Stumpo, Deborah J.
Blackshear, Perry J.
Sarkar, Rajabrata
Monahan, Thomas S.
Myristoylated Alanine‐Rich Protein Kinase Substrate (MARCKS) Regulates Small GTPase Rac1 and Cdc42 Activity and Is a Critical Mediator of Vascular Smooth Muscle Cell Migration in Intimal Hyperplasia Formation
title Myristoylated Alanine‐Rich Protein Kinase Substrate (MARCKS) Regulates Small GTPase Rac1 and Cdc42 Activity and Is a Critical Mediator of Vascular Smooth Muscle Cell Migration in Intimal Hyperplasia Formation
title_full Myristoylated Alanine‐Rich Protein Kinase Substrate (MARCKS) Regulates Small GTPase Rac1 and Cdc42 Activity and Is a Critical Mediator of Vascular Smooth Muscle Cell Migration in Intimal Hyperplasia Formation
title_fullStr Myristoylated Alanine‐Rich Protein Kinase Substrate (MARCKS) Regulates Small GTPase Rac1 and Cdc42 Activity and Is a Critical Mediator of Vascular Smooth Muscle Cell Migration in Intimal Hyperplasia Formation
title_full_unstemmed Myristoylated Alanine‐Rich Protein Kinase Substrate (MARCKS) Regulates Small GTPase Rac1 and Cdc42 Activity and Is a Critical Mediator of Vascular Smooth Muscle Cell Migration in Intimal Hyperplasia Formation
title_short Myristoylated Alanine‐Rich Protein Kinase Substrate (MARCKS) Regulates Small GTPase Rac1 and Cdc42 Activity and Is a Critical Mediator of Vascular Smooth Muscle Cell Migration in Intimal Hyperplasia Formation
title_sort myristoylated alanine‐rich protein kinase substrate (marcks) regulates small gtpase rac1 and cdc42 activity and is a critical mediator of vascular smooth muscle cell migration in intimal hyperplasia formation
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845127/
https://www.ncbi.nlm.nih.gov/pubmed/26450120
http://dx.doi.org/10.1161/JAHA.115.002255
work_keys_str_mv AT yudan myristoylatedalaninerichproteinkinasesubstratemarcksregulatessmallgtpaserac1andcdc42activityandisacriticalmediatorofvascularsmoothmusclecellmigrationinintimalhyperplasiaformation
AT makkargeorge myristoylatedalaninerichproteinkinasesubstratemarcksregulatessmallgtpaserac1andcdc42activityandisacriticalmediatorofvascularsmoothmusclecellmigrationinintimalhyperplasiaformation
AT stricklanddudleyk myristoylatedalaninerichproteinkinasesubstratemarcksregulatessmallgtpaserac1andcdc42activityandisacriticalmediatorofvascularsmoothmusclecellmigrationinintimalhyperplasiaformation
AT blanpiedthomasa myristoylatedalaninerichproteinkinasesubstratemarcksregulatessmallgtpaserac1andcdc42activityandisacriticalmediatorofvascularsmoothmusclecellmigrationinintimalhyperplasiaformation
AT stumpodeborahj myristoylatedalaninerichproteinkinasesubstratemarcksregulatessmallgtpaserac1andcdc42activityandisacriticalmediatorofvascularsmoothmusclecellmigrationinintimalhyperplasiaformation
AT blackshearperryj myristoylatedalaninerichproteinkinasesubstratemarcksregulatessmallgtpaserac1andcdc42activityandisacriticalmediatorofvascularsmoothmusclecellmigrationinintimalhyperplasiaformation
AT sarkarrajabrata myristoylatedalaninerichproteinkinasesubstratemarcksregulatessmallgtpaserac1andcdc42activityandisacriticalmediatorofvascularsmoothmusclecellmigrationinintimalhyperplasiaformation
AT monahanthomass myristoylatedalaninerichproteinkinasesubstratemarcksregulatessmallgtpaserac1andcdc42activityandisacriticalmediatorofvascularsmoothmusclecellmigrationinintimalhyperplasiaformation